Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes Reply

被引：0
|
作者：
Kosmaczewska, Agata [1 ]
Frydecka, Irena [1 ]
机构：
[1] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Ul R Weigla 12, PL-53114 Wroclaw, Poland
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2020年 / 130卷 / 10期
关键词：
D O I：
10.20452/pamw.15660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：920 / 921
页数：2
相关论文
共 50 条
  • [1] Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes
    Marcinkiewicz, Janusz
    Mazurek, Henryk
    Majka, Grzegorz
    Chain, Benjamin
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (10): : 919 - 920
  • [2] COVID-19 outcomes in people with cystic fibrosis
    Burgel, Pierre-Regis
    Goss, Christopher
    CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (06) : 538 - 543
  • [3] Increased COVID-19 Infection Risk Drives Racial and Ethnic Disparities in Severe COVID-19 Outcomes
    Shortreed, Susan M.
    Gray, Regan
    Akosile, Mary Abisola
    Walker, Rod L.
    Fuller, Sharon
    Temposky, Lisa
    Fortmann, Stephen P.
    Albertson-Junkans, Ladia
    Floyd, James S.
    Bayliss, Elizabeth A.
    Harrington, Laura B.
    Lee, Mi H.
    Dublin, Sascha
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2023, 10 (01) : 149 - 159
  • [4] Increased COVID-19 Infection Risk Drives Racial and Ethnic Disparities in Severe COVID-19 Outcomes
    Susan M. Shortreed
    Regan Gray
    Mary Abisola Akosile
    Rod L. Walker
    Sharon Fuller
    Lisa Temposky
    Stephen P. Fortmann
    Ladia Albertson-Junkans
    James S. Floyd
    Elizabeth A. Bayliss
    Laura B. Harrington
    Mi H. Lee
    Sascha Dublin
    Journal of Racial and Ethnic Health Disparities, 2023, 10 : 149 - 159
  • [5] Cystic Fibrosis and COVID-19
    Chapman, Kyle D.
    Moffett, Kathryn S.
    SOUTHERN MEDICAL JOURNAL, 2020, 113 (09) : 422 - 422
  • [6] Metformin use and risk for COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Kuntz, Jennifer
    Floyd, James
    Walker, Rod
    Fortmann, Stephen
    Bayliss, Elizabeth
    Shortreed, Susan
    Harrington, Laura
    Lee, Mi
    Albertson-Junkans, Ladia
    Powers, John
    Fuller, Sharon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 506 - 506
  • [7] Undervaccination and severe COVID-19 outcomes reply
    Kerr, Steven
    Robertson, Chris
    Sheikh, Aziz
    LANCET, 2025, 405 (10475): : 302 - 302
  • [8] Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
    Mahmood, Saad B. Z.
    Majid, Hafsa
    Arshad, Ainan
    Zaib-Un-Nisa, Noureen
    Niazali, Noureen
    Kazi, Kulsum
    Aslam, Aashir
    Ahmed, Sibtain
    Jamil, Bushra
    Jafri, Lena
    CLINICAL LABORATORY, 2023, 69 (06) : 1126 - 1133
  • [9] Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19
    Fromonot, Julien
    Gette, Mickael
    Ben Lassoued, Amin
    Gueant, Jean-Louis
    Gueant-Rodriguez, Rosa-Maria
    Guieu, Regis
    CLINICAL NUTRITION, 2022, 41 (12) : 3115 - 3119
  • [10] COVID-19: Risk factors for increased mortality in younger COVID-19 patients
    不详
    ERNAHRUNGS UMSCHAU, 2022, 69 (06): : M297 - M297
12345